Your browser doesn't support javascript.
loading
Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary.
Sue-A-Quan, Rachel; Patel, Palak G; Shakfa, Noor; Nyi, May-Phyo Nyi; Afriyie-Asante, Afrakoma; Kang, Eun Young; Köbel, Martin; Koti, Madhuri.
  • Sue-A-Quan R; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada; Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
  • Patel PG; Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada; Department of Cell Biology, The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Department of Pathology and Molecular Medicine, Qu
  • Shakfa N; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada; Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
  • Nyi MN; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
  • Afriyie-Asante A; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada; Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
  • Kang EY; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Koti M; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada; Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada; Department of Obstetrics and Gynecology, Kingston Health Sciences Center, Queen's University,
Gynecol Oncol ; 162(2): 421-430, 2021 08.
Article en En | MEDLINE | ID: mdl-34088514
ABSTRACT

OBJECTIVE:

To define the pre-treatment tumour immune landscape of clear cell carcinoma of the ovary (CCOC).

METHODS:

We investigated the infiltration profiles of selected immune cell populations and immune checkpoint proteins that have been previously shown to have prognostic relevance in high grade serous carcinoma of the ovary to determine their association with clinical outcomes in CCOC patients. Using multiplex immunohistochemistry, we evaluated the density of CD3+, FoxP3+, CD8+ T cells, CD20+ B cells and expression of PD-1, PD-L1 and IDO1 immune checkpoints in a cohort of 162 CCOC tumour specimens on a tissue microarray.

RESULTS:

Increased infiltration of CD3+ CD8- (helper T) cells, CD8+ (cytotoxic T) cells, and CD68+ macrophages significantly associated with shorter disease-free survival, recurrence-free survival and overall survival. Importantly, higher expression of PD-L1 and IDO-1 immune checkpoints was associated with better clinical outcomes.

CONCLUSION:

Findings from our study are foundational towards the development of immune classifiers and biomarkers of response to immune checkpoint blockade therapy in CCOC.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ovario / Carcinoma / Microambiente Tumoral / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ovario / Carcinoma / Microambiente Tumoral / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article